The largest database of trusted experimental protocols

Ms macs separation column

Manufactured by Miltenyi Biotec
Sourced in Germany, France

The MS MACS separation column is a tool designed for magnetic cell separation. It facilitates the isolation and purification of target cells from a heterogeneous cell population using magnetic beads coated with specific antibodies. The column's core function is to effectively separate and capture the desired cell types, enabling researchers to obtain purified cell samples for further analysis and applications.

Automatically generated - may contain errors

6 protocols using ms macs separation column

1

Isolation and Expansion of Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
iECs were isolated and expanded as described previously.[66, 67] In brief, CD31‐expressing cells were isolated via magnetic‐activated cell sorting (MACS; Miltenyi Biotec Bergisch Gladbach), following the manufacturer's protocol, on day 8 of differentiation. After rinsing the cells with 1x phosphate‐buffered saline (PBS; Thermo Fisher Scientific), cells were trypsinized with TrypLE Express and resuspended in MACS buffer (0.5 Ethylenediaminetetraacetic acid [MilliporeSigma] and 0.5% Bovine Serum Albumin (BSA; [MilliporeSigma] in PBS). After resuspension, cells were incubated with 10 µL of PE‐conjugated anti‐human CD31 (BD Biosciences) for 10 min at 4 °C. To remove the unbound primary antibody, cells were washed twice with MACS buffer. After washing, cells were resuspended in 80 µL MACS buffer, and 20 µL of anti‐PE microbeads (Miltenyi Biotec Bergisch Gladbach) were added to the cell suspension. Cells were incubated for an additional 15 min at 4 °C, followed by a washing step with MACS buffer before separation using the MS MACS separation column (Miltenyi Biotec Bergisch Gladbach). Finally, CD31+ cells were seeded on collagen type I‐coated plates and maintained in ECGM supplemented with 50 ng mL−1 VEGF and 10 × 10−6 m SB‐431542.
+ Open protocol
+ Expand
2

Isolation and Culture of CD31+ Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD31 expressing cells were isolated on day 8 of differentiation via magnetically activated cell sorting (MACS; Miltenyi Biotec Bergisch Gladbach, Germany) following the manufacturer’s protocol. After washing with 1× phosphate-buffered saline (PBS, ThermoFisher Scientific), cells were harvested with TrypLE Express and resuspended in MACS buffer (0.5 EDTA and 0.5% BSA in PBS). Cells were then incubated with 10 μl of PE-conjugated anti-human CD31 (BD Biosciences, San Jose, CA) for 10 min at 4 °C. After incubation, the unbound primary antibody was removed by washing with MACS buffer twice. Next, 20 μl of anti-PE microbeads (Miltenyi Biotec Bergisch Gladbach, Germany) were added to 80 μl of cells suspended in MACS buffer and incubated for an additional 15 min at 4 °C. Cells were washed with MACS buffer and separated using the MS MACS separation column (Miltenyi Biotec). Following separation, CD31 and VECAD enrichment were confirmed using flow cytometry as previously71 (link) and detailed below in a separate section. Finally, CD31+ cells were seeded on type I collagen-coated plates and maintained in EC differentiation media. For all experiments, media was switched to ECGM without growth factor supplementation for 24 h unless otherwise noted. All experiments used iECs between passages 1 and 3.
+ Open protocol
+ Expand
3

Isolation and Expansion of hiPSC-Derived ECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolation and Expansion of hiPSC Derived ECs CD31 or VECad expressing cells were isolated via magnetic activated cell sorting (MACS; Miltenyi Biotec) following the manufacturer's protocol on day 12 of EVC differentiation. Briefly, after washing one time with 1x phosphate buffered saline (PBS, Sigma), EVCs were harvested with TrypLE dissociation buffer (Invitrogen), re-suspended in MACS buffer (0.5 EDTA and 0.5% BSA in PBS) and incubated with 10 ml of PE-conjugated anti-human VECad (BD Biosciences) for 10 minutes at 4 C. After incubation, unbound primary antibody was removed by washing with MACS buffer. Next, 20 ml of anti-PE microbeads (Miltenyi Biotec) were added to 80 ml of cells suspended in MACS buffer and incubated for an additional 15 minutes at 4 C. Cells were washed three times with MACS buffer and separated using the MS MACS separation column (Miltenyi Biotec). Following separation VECad enrichment was confirmed using flow cytometry. Finally, VECad+ cells were seeded on type IV collagen coated plates and maintained in EC differentiation media.
+ Open protocol
+ Expand
4

Myeloma Patient Specimen Processing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient specimens were from myeloma patients who provided written informed consent through the Moffitt Total Cancer Care® (MCC# 18608) tissue banking protocol per institutional and IRB regulations. Samples were provided to the laboratory as a de-identified sample from the Moffitt Tissue Core. Mononuclear cells were separated from human bone marrow aspirates with the use of Ficoll-Paque PLUS (GE Healthcare, UK). After separation, CD138-positive cells were sorted using MS MACS Separation Columns (Miltenyi Biotec, Germany) and CD138 microbeads (Miltenyi) per manufacturer’s instructions. For flow cytometry assays using Annexin V and FACS analysis to detect dead cells, CD138 cells were seeded at 1 million cells/ml in a 96 well plate (100 ul volume) per patient sample. The cell plating density was consistent across all specimens tested.
+ Open protocol
+ Expand
5

Hematopoietic Support by iPSC-Derived MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSC-like cells generated from hiPSC were seeded at 30,000 cells/cm2 in 96-well plate (n = 5) onto 0.1% gelatine-coated wells in MSC medium. At 100% confluence, the cells were irradiated at 10 Gy for 10 min. The same day, CD34+ hematopoietic progenitor cells were isolated from cord blood by magnetic labelling using the Indirect CD34 MicroBead Kit (130–046–701; Miltenyi) on MS MACS separation columns (Miltenyi) following manufacturer's instructions, and seeded at 5000 cells/cm2 on top of MSC-like cells in myelocult H5100 (05,150; STEMCELL Technologies) supplemented with 10−6 hydrocortisone (H0888; Sigma-Aldrich). Co-cultures were maintained for 5 weeks with medium changes every other day and then evaluated by optical microscopy analysis on a Nikon Eclipse Ti microscope (Nikon) for the formation of typical cobblestone areas and by flow cytometry using CD45-APC—C7 (561,863; BD; RRID: AB_10,897,014) and CD34-FITC antibodies (555,821; BD; RRID: AB_396,150) to assess support of hematopoietic cells, following the protocols already described above.
+ Open protocol
+ Expand
6

Tetrameric Antigen-Coupled Magnetic Enrichment

Check if the same lab product or an alternative is used in the 5 most similar protocols
TAME was performed as previously described (Alanio et al., 2010 (link); Alanio et al., 2013 (link); Kyewski and Klein, 2006 (link)). Briefly, purified PBMCs (2x107 to 4x108) were incubated with FcR blocking reagent (Miltenyi, France), then stained with PE and/or APC pMHC-multimers at 20nM final concentration for 30 min. Samples were incubated with anti-PE-microbeads and positive selection was performed using MS MACS separation columns (Miltenyi, France). Unbound cells (“Depleted” fraction) were collected. Bound cells (“Enriched” fraction) were eluted. As previously published(Alanio et al., 2010 (link)), tetramer-positive populations were gated as LiveDump-CD8+Tetramer+ cells. To approximate the number of the epitope-specific T cells within each sample, we used a calculation previously described by Moon et al (Arstila et al., 1999 (link); Moon et al., 2009 (link)). Precursor frequency is defined as the number of tetramer-positive events in the “Enriched” fraction divided by the number of total CD8+ in the sample.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!